CCO Treatment Updates

Optimizing Treatment Choices in Ovarian Cancer

Virtual Presentations

Early Detection and Treatment of Ovarian Cancer

Faculty:

Judith K. Wolf, MD

CME CREDIT INFORMATION

Release Date: 04/25/08

Expiration Date: 04/24/09

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Judith K. Wolf, MD, discusses risk factors, screening strategies, and prophylactic surgery in the setting of ovarian cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

Cite risk factors associated with prognosis in patients with ovarian cancer
Discuss screening strategies for ovarian cancer patients
Explain the risks and benefits of prophylactic surgery in the setting of ovarian cancer

The Importance of Early Detection and Treatment of Ovarian Cancer

Downloadable slidesets including how to identify risk factors, as well as screening and prevention strategies for ovarian cancer patients.

Format: Microsoft PowerPoint (.ppt) | File size: 428 KB

Current Controversies in the Management of Recurrent Ovarian Cancer

Faculty:

Robert F. Ozols, MD, PhD

CME CREDIT INFORMATION

Release Date: 04/28/08

Expiration Date: 04/27/09

Physicians: maximum of 0.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Robert F. Ozols, MD, PhD, discusses current clinical management strategies for patients with recurrent ovarian cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

Define the magnitude of the clinical issue of recurrent ovarian cancer
Discuss the use of chemotherapy for the treatment of patients with platinum-sensitive recurrent ovarian cancer
Explain therapeutic strategies under investigation for the treatment of patients with platinum-resistant ovarian cancer

Current Controversies in the Management of Recurrent Ovarian Cancer

Downloadable slidesets on controversial topics and treatment approaches for managing recurrent ovarian cancer patients

Format: Microsoft PowerPoint (.ppt) | File size: 410 KB

New Agents for the Management of Ovarian Cancer

Faculty:

Bradley J. Monk, MD

CME CREDIT INFORMATION

Release Date: 05/02/08

Expiration Date: 05/01/09

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Bradley J. Monk, MD, discusses new agents and strategies for the clinical management of patients with ovarian cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss results of recent clinical trials of monoclonal antibodies used in the clinical management of ovarian cancer
Describe novel agents used in the treatment of patients with ovarian cancer
Cite clinical trials comparing novel agents with standard chemotherapies used in the clinical management of patients with ovarian cancer

New Agents for the Management of Ovarian Cancer

Downloadable slidesets on new agents in development for recurrent ovarian cancer patients

Format: Microsoft PowerPoint (.ppt) | File size: 2.14 MB

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.